Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*
Bone Growth Stimulators Market by Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, and Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), and Distribution Channel (Hospitals & Clinics, Home Care, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
| A06065 | Pages: 238 | Mar 2020 | 1602 Views | | |
| Author(s) : Onkar Sumant & Sayali Shinde | Tables: 114 | Charts: 39 | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Bone Growth Stimulators Market
Request Now !The global bone growth stimulators market size was valued at $1,242 million in 2018, and is estimated to reach at $1,869 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Bone growth stimulator devices are the medical devices that boost the fracture healing process in cases of delay or failure. They raise the natural speed of healing by giving electric shocks to patients. Some bone growth stimulators available in the market include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. There are three types of bone growth stimulation devices, which include pulsed electromagnetic field devices, capacitive coupling devices, and combined magnetic field devices.
Get more information on this report : Request Sample Pages
Rise in geriatric population; increase in incidences of fracture and accidents; rise in prevalence of arthritis; surge in cases of diabetes and other medical conditions such as obesity, vascular disease, and renal disorders; rise in inclination of patients toward minimally invasive & non-invasive surgical treatments; rise in platelet-rich plasma and bone morphogenetic proteins; and availability of cost effective bone growth stimulation devices are the major factors that drive the growth of the global bone growth stimulators market. In addition, surge in patient awareness regarding bone growth stimulators, procedural benefits provided by bone growth stimulation devices in bone fracture treatment and orthopedic diseases, rise in technological advancements in bone growth stimulators, and increase in adoption rate for bone growth stimulators by both patients and prescribers are other factors that contribute toward the growth of the bone growth stimulators market. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.
Bone Growth Stimulators Market Segmentation
The bone growth stimulators market is segmented into product, application, distribution channel, and region. By product, it is categorized into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. Depending on application, it is classified into spinal fusion surgeries, delayed union & nonunion bone fractures, oral & maxillofacial surgeries, and others. By distribution channel, it is divided into hospitals & clinics, home care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segment review
By product, the bone growth stimulation devices was the major revenue contributor in 2018, and is projected to grow significantly during the forecast period. The key factors that drive the bone growth stimulators market growth are rise in demand for bone growth stimulation devices, rise in geriatric population, increase in incidence of spinal deformities, technological advancements, development in bone growth stimulation devices, and rise in number of bone and joint problems.
Bone Growth Stimulators Market
By Product
Bone growth stimulation devices is projected as one of the most lucrative segment.
Get more information on this report : Request Sample Pages
On the basis of application, the spinal fusion surgeries segment accounted for the majority of the bone growth stimulators market share in 2018, owing to rise in incidences of spinal disorders, adoption rate of minimally invasive spinal surgeries, rise in technological advancements in spinal surgery, increase in incidence of obesity & degenerative spinal conditions, and increase in patient preference toward spinal fusion surgery procedures across the globe.
Bone Growth Stimulators Market
By Application
Spinal fusion surgeries holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.
Get more information on this report : Request Sample Pages
Snapshot of Asia-Pacific bone growth stimulators market
Asia-Pacific presents lucrative opportunities for the key players operating in the bone growth stimulators market due to increase in patient awareness toward benefits offered by bone growth stimulators, rise in number of hospitals equipped with advanced medical facilities, development of R&D sector, rise in healthcare reforms, and technological advancements in bone growth stimulators products. Moreover, rise in demand for bone growth stimulators and presence of high population base and income contribute toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high bone growth stimulators market share is also expected to drive the growth of the bone growth stimulators market in the region.
Bone Growth Stimulators Market
By Geography
Asia-Pacific region would exhibit the highest CAGR of 7.0% during 2019-2026.
Get more information on this report : Request Sample Pages
The key players profiled in this report include Arthrex, Inc., Essex Woodlands Healthcare Partners (Bioventus LLC), Colfax Corporation (DJO Global, Inc), Isto Biologics, Johnson & Johnson (Depuy Synthes), Medtronic Plc, Orthofix Medical Inc., Stryker Corporation, Terumo Corporation, and Zimmer Biomet Holdings, Inc.
Key Benefits for Stakeholders:
- The study provides an in-depth analysis of the bone growth stimulators market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers bone growth stimulators market analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global bone growth stimulators market growth.
Key Market Segments:
By Product
- Bone Growth Stimulation Devices
- Bone Morphogenetic Proteins
- Platelet-Rich Plasma
By Application
- Spinal Fusion Surgeries
- Delayed Union & Nonunion Bone Fractures
- Oral & Maxillofacial Surgeries
- Others
By Distribution Channel
- Hospitals & Clinics
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market player positioning, 2018
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in demand for noninvasive and safer surgical treatments
3.4.1.2. Increase in number of patients demanding bone growth stimulators
3.4.1.3. Increase in government expenditure on healthcare
3.4.2. Restraint
3.4.2.1. Stringent approval process of bone growth stimulators
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.4. Impact analysis
CHAPTER 4: BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Bone growth stimulation devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Bone Morphogenetic Proteins
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Platelet-rich plasma
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal Fusion Surgeries
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Delayed Union & Nonunion Bone Fractures
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Oral & Maxillofacial Surgeries
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Home Care
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: BONE GROWTH STIMULATORS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. bone growth stimulators market, by product
7.2.2.1.2. U.S. bone growth stimulators market, by application
7.2.2.1.3. U.S. bone growth stimulators market, by distribution channel
7.2.2.2. Canada
7.2.2.2.1. Canada bone growth stimulators market, by product
7.2.2.2.2. Canada bone growth stimulators market, by application
7.2.2.2.3. Canada bone growth stimulators market, by distribution channel
7.2.2.3. Mexico
7.2.2.3.1. Mexico bone growth stimulators market, by product
7.2.2.3.2. Mexico bone growth stimulators market, by application
7.2.2.3.3. Mexico bone growth stimulators market, by distribution channel
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by distribution channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany bone growth stimulators market, by product
7.3.2.1.2. Germany bone growth stimulators market, by application
7.3.2.1.3. Germany bone growth stimulators market, by distribution channel
7.3.2.2. France
7.3.2.2.1. France bone growth stimulators market, by product
7.3.2.2.2. France bone growth stimulators market, by application
7.3.2.2.3. France bone growth stimulators market, by distribution channel
7.3.2.3. UK
7.3.2.3.1. UK bone growth stimulators market, by product
7.3.2.3.2. UK bone growth stimulators market, by application
7.3.2.3.3. UK bone growth stimulators market, by distribution channel
7.3.2.4. Italy
7.3.2.4.1. Italy bone growth stimulators market, by product
7.3.2.4.2. Italy bone growth stimulators market, by application
7.3.2.4.3. Italy bone growth stimulators market, by distribution channel
7.3.2.5. Spain
7.3.2.5.1. Spain bone growth stimulators market, by product
7.3.2.5.2. Spain bone growth stimulators market, by application
7.3.2.5.3. Spain bone growth stimulators market, by distribution channel
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe bone growth stimulators market, by product
7.3.2.6.2. Rest of Europe bone growth stimulators market, by application
7.3.2.6.3. Rest of Europe bone growth stimulators market, by distribution channel
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan bone growth stimulators market, by product
7.4.2.1.2. Japan bone growth stimulators market, by application
7.4.2.1.3. Japan bone growth stimulators market, by distribution channel
7.4.2.2. China
7.4.2.2.1. China bone growth stimulators market, by product
7.4.2.2.2. China bone growth stimulators market, by application
7.4.2.2.3. China bone growth stimulators market, by distribution channel
7.4.2.3. Australia
7.4.2.3.1. Australia bone growth stimulators market, by product
7.4.2.3.2. Australia bone growth stimulators market, by application
7.4.2.3.3. Australia bone growth stimulators market, by distribution channel
7.4.2.4. India
7.4.2.4.1. India bone growth stimulators market, by product
7.4.2.4.2. India bone growth stimulators market, by application
7.4.2.4.3. India bone growth stimulators market, by distribution channel
7.4.2.5. South Korea
7.4.2.5.1. South Korea bone growth stimulators market, by product
7.4.2.5.2. South Korea bone growth stimulators market, by application
7.4.2.5.3. South Korea bone growth stimulators market, by distribution channel
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific bone growth stimulators market, by product
7.4.2.6.2. Rest of Asia-Pacific bone growth stimulators market, by application
7.4.2.6.3. Rest of Asia-Pacific bone growth stimulators market, by distribution channel
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by distribution channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil bone growth stimulators market, by product
7.5.2.1.2. Brazil bone growth stimulators market, by application
7.5.2.1.3. Brazil bone growth stimulators market, by distribution channel
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia bone growth stimulators market, by product
7.5.2.2.2. Saudi Arabia bone growth stimulators market, by application
7.5.2.2.3. Saudi Arabia bone growth stimulators market, by distribution channel
7.5.2.3. South Africa
7.5.2.3.1. South Africa bone growth stimulators market, by product
7.5.2.3.2. South Africa bone growth stimulators market, by application
7.5.2.3.3. South Africa bone growth stimulators market, by distribution channel
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA bone growth stimulators market, by product
7.5.2.4.2. Rest of LAMEA bone growth stimulators market, by application
7.5.2.4.3. Rest of LAMEA bone growth stimulators market, by distribution channel
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by distribution channel
CHAPTER 8: COMPANY PROFILES
8.1. Arthrex, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.2. Essex Woodlands Healthcare Partners (Bioventus LLC)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.1. Key strategic moves and developments
8.3. Colfax Corporation (DJO Global, Inc)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Isto Biologics
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. JOHNSON & JOHNSON (DEPUY SYNTHES)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Orthofix Medical Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. STRYKER CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Terumo Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. ZIMMER BIOMET HOLDINGS, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. BONE GROWTH STIMULATION DEVICES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. BONE MORPHOGENETIC PROTEINS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. PLATELET-RICH PLASMA BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05. GLOBAL BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 06. SPINAL FUSION SURGERIES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07. DELAYED UNION & NONUNION BONE FRACTURES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. ORAL AND MAXILLOFACIAL SURGERIES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. OTHERS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. GLOBAL BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 11. HOSPITALS & CLINICS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 12. HOME CARE BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13. OTHERS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14. BONE GROWTH STIMULATORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. U.S. BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 17. U.S. BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 18. U.S. BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 19. CANADA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 20. CANADA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 21. CANADA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 22. MEXICO BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 23. MEXICO BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 24. MEXICO BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 25. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 26. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 27. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 28. EUROPE BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 29. GERMANY BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 30. GERMANY BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 31. GERMANY BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 32. FRANCE BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 33. FRANCE BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 34. FRANCE BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 35. UK BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 36. UK BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 37. UK BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 38. ITALY BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 39. ITALY BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 40. ITALY BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 41. SPAIN BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 42. SPAIN BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 43. SPAIN BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 44. REST OF EUROPE BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 45. REST OF EUROPE BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 46. REST OF EUROPE BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 47. EUROPE BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 48. EUROPE BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 49. EUROPE BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 50. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 51. JAPAN BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 52. JAPAN BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 53. JAPAN BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 54. CHINA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 55. CHINA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 56. CHINA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 57. AUSTRALIA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 58. AUSTRALIA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 59. AUSTRALIA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 60. INDIA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 61. INDIA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 62. INDIA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 63. SOUTH KOREA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 64. SOUTH KOREA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 65. SOUTH KOREA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 66. REST OF ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 67. REST OF ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 68. REST OF ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 69. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 70. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 71. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 72. LAMEA BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 73. BRAZIL BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 74. BRAZIL BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 75. BRAZIL BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 76. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 77. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 78. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 79. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 80. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 81. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 82. REST OF LAMEA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 83. REST OF LAMEA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 84. REST OF LAMEA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 85. LAMEA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 86. LAMEA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 87. LAMEA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 88. ARTHREX: COMPANY SNAPSHOT
TABLE 89. ARTHREX: PRODUCT PORTFOLIO
TABLE 90. EW HEALTHCARE: COMPANY SNAPSHOT
TABLE 91. EW HEALTHCARE: PRODUCT PORTFOLIO
TABLE 92. COLFAX: COMPANY SNAPSHOT
TABLE 93. COLFAX: OPERATING SEGMENTS
TABLE 94. COLFAX: PRODUCT PORTFOLIO
TABLE 95. ISTO: COMPANY SNAPSHOT
TABLE 96. ISTO: PRODUCT PORTFOLIO
TABLE 97. J&J: COMPANY SNAPSHOT
TABLE 98. J&J: OPERATING SEGMENTS
TABLE 99. J&J: PRODUCT TYPE PORTFOLIO
TABLE 100. MEDTRONIC: COMPANY SNAPSHOT
TABLE 101. MEDTRONIC: OPERATING SEGMENTS
TABLE 102. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 103. ORTHOFIX: COMPANY SNAPSHOT
TABLE 104. ORTHOFIX: OPERATING SEGMENTS
TABLE 105. ORTHOFIX: PRODUCT PORTFOLIO
TABLE 106. STRYKER: COMPANY SNAPSHOT
TABLE 107. STRYKER: OPERATING SEGMENTS
TABLE 108. STRYKER: PRODUCT PORTFOLIO
TABLE 109. TERUMO: COMPANY SNAPSHOT
TABLE 110. TERUMO: OPERATING SEGMENTS
TABLE 111. TERUMO: PRODUCT PORTFOLIO
TABLE 112. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 113. ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 114. ZIMMER BIOMET: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL BONE GROWTH STIMULATORS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MARKET PLAYER POSITIONING, 2018
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
FIGURE 08. HIGH INTENSITY OF RIVALRY
FIGURE 09. IMPACT ANALYSIS
FIGURE 10. COMPARATIVE ANALYSIS OF BONE GROWTH STIMULATION DEVICES BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 11. COMPARATIVE ANALYSIS OF BONE MORPHOGENETIC PROTEINS BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF PLATELET-RICH PLASMA BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF SPINAL FUSION SURGERIES BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS DELAYED UNION & NONUNION BONE FRACTURES BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF ORAL AND MAXILLOFACIAL SURGERIES BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF OTHERS BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF HOSPITALS & CLINICS BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF HOME CARE BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF OTHERS BONE GROWTH STIMULATORS TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 20. COLFAX: NET SALES, 2016–2018 ($MILLION)
FIGURE 21. COLFAX: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 22. COLFAX: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 23. J&J: REVENUE, 2016–2018 ($MILLION)
FIGURE 24. J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 25. J&J: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 26. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 27. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 29. ORTHOFIX: NET SALES, 2016–2018 ($MILLION)
FIGURE 30. ORTHOFIX: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 31. ORTHOFIX: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 32. STRYKER: NET SALES, 2016–2018 ($MILLION)
FIGURE 33. STRYKER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 34. TERUMO: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. TERUMO: REVENUE SHARE BY PRODUCT, 2018 (%)
FIGURE 36. TERUMO: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. ZIMMER BIOMET: REVENUE, 2016–2018 ($MILLION)
FIGURE 38. ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. ZIMMER BIOMET: REVENUE SHARE BY REGION, 2018 (%)
Bone growth stimulator devices are used to improve healing process during the treatment of disorders such as orthopedic fixation, bone fractures spinal fixation, and others. It enhances the healing process by stimulating the production of new bone cells, which allows fractures to heal at a considerably faster rate. Moreover, bone growth stimulators are useful in spinal fusion surgeries, delayed union & nonunion bone fractures, and oral & maxillofacial surgeries.
Technological advancements in bone growth stimulators products, rise in geriatric population, rise in number of trauma and accident cases, and surge in inclination of patients toward minimally invasive & non-invasive surgical treatments significantly boost the growth of the bone growth stimulators market. Moreover, rise in adoption rate for bone growth stimulators by both patients & prescribers, increase in healthcare expenditure in developed and developing regions, and rapid demand and adoption of platelet-rich plasma and bone morphogenetic proteins fuel the growth of the global bone growth stimulators market.
North America is expected to remain dominant during the forecast period, due to development of technologically advanced bone growth stimulators and rise in number of hospitals and home care centers. Conversely, Asia-Pacific is expected to offer lucrative opportunities to the key players during the forecast period, due to development in the R&D and healthcare sectors along with rise in demand for bone growth stimulator products.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Download Sample
Purchase Full Report of
Bone Growth Stimulators Market
- Online Only
- $3,456
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,840
- Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5,769
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,450
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $8,995
- Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading instantly.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers